Harriet Grantham

About

Marketing Executive Following her early career in PR and marketing, Harriet has spent a great deal of time working in market research, with a particular focus on health in aging and elderly care.
11 POSTS

/

0 COMMENTS

Articles

Telomeres extend lifespan without genetic mods

The Spanish National Cancer Research Centre (CNIO) have discovered a way for telomeres to extend the lifespan of mice without genetic modification. Scientists have been...

FDA grants AliveCor first-ever clearance for smartphone ECG

AliveCor announces the launch of KardiaMobile 6L, the world’s first six-lead consumer heart monitoring device to get FDA approval. Using your phone to prevent strokes...

AI tool detects heart failure from a single heartbeat

Researchers develop a neural diagnostic tool which can detect cardiac anomalies with 100% accuracy Artificial intelligence (AI) has now taken another step forward in healthcare,...

Unique molecule discovered that reverses memory loss

Breakthrough by Stanford University researchers reverses brain decline by disabling a unique molecule to improve cognitive healthspan. New research conducted by neurobiologist Tony Wyss-Coray’s team...

Contact lens set to revolutionise medical diagnoses – and lifespan

An eye for an eye - the future of wearable contact lens tech will soon be keeping an eye on our health. Imagine a world...

Deprenyl Parkinson’s drug increases lifespan in rats

Deprenyl increases the lifespan of rats by up to 34% - could it do the same for humans? Deprenyl, marketed as Selegiline, is a Parkinson’s...

DNA repair breakthrough brings NAD closer

Longevity moonshot therapy sparks interest from NASA with signalling molecule NAD. Our DNA gets damaged every day; this damage can come about from various sources,...

AstraZeneca joins with BenevolentAI for drug discovery

Strategic partnership between AstraZeneca and BenevolentAI to use artificial intelligence and machine learning to identify new kidney and lung drugs. Pharma giant AstraZeneca has announced...

Glenmark Pharma commercialises Remogliflozin

India becomes the first country to get access to innovative new treatment for type-2 diabetes with Remogliflozin. Glenmark Pharmaceuticals has become the first organisation to...